A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy

Stopped Patient enrollment was hard mainly due to we need at least three lesions suitable for SBRT

Conditions

• Carcinoma, Non-Small-Cell Lung

Interventions

• RADIATION: Stereotactic body radiotherapy
• DRUG: rhGM-CSF

Sponsor

Wuhan University

Collaborators

• [object Object]
• [object Object]